You may be right but not because the treatment doesn't work. imo, the powerful drug lobby and FDA prevents stem cell therapy from advancing as it should. The price difference between so many money losing drug companies priced in hundreds of $ vs stem cell co rarely reaching even $5 is criminal.
I agree and might add that falling dollar will also help going forward
Recently sold but should have held a few more days. Not seeing any real news to account for the surge last week other than what you mentioned. That said, funny that the stock finally started moving day shelf offering updated. I only see shares being sold by existing shareholders and no proceeds going to the company. Monitoring as well to see if any institutions take positions.
you are right about that